Skip to content

Meera V. Ragavan, MD, MPH

Meera   Ragavan, MD, MPH

Meera Ragavan, MD, MPH, is a research scientist at the Kaiser Permanente Northern California Division of Research and practicing board-certified medical oncologist at Kaiser Permanente San Francisco Medical Center. Dr. Ragavan’s research interests are centered around mitigating issues of access, affordability, and equity in cancer care delivery. She specifically studies barriers to clinical trial enrollment, financial hardship, and disparities in guideline-concordant care with a focus on patients with lung cancer. She has published in numerous journals and spoken at regional and national conferences on these topics. Most recently, she secured a Young Investigator Award through the American Society of Clinical Oncology to study the impact of financial assistance programs on clinical outcomes for patients prescribed oral anti-cancer medications. She also served as an editorial fellow for the Journal of Clinical Oncology- Oncology Practice.

Dr. Ragavan earned her undergraduate degrees in biology and economics at the University of Pennsylvania in the Vagelos Life Sciences and Management program. She went on to complete her medical degree at Stanford University School of Medicine and her internal medicine residency at Stanford Health Care before pursuing an oncology fellowship at the University of California, San Francisco, where she served as chief fellow. She additionally holds a Master’s of Public Health with a focus in health policy from the Harvard T.H. Chan School of Public Health.


Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy.

Authors: Ragavan, Meera V;Swartz, Scott;Clark, Mackenzie;Lo, Mimi;Gupta, Arjun;Chino, Fumiko;Lin, Tracy Kuo

JCO Oncol Pract. 2024 Jan 04:OP2300446. doi: 10.1200/OP.23.00446..

PubMed abstract

The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.

Authors: Jansen, Jeroen P;Ragavan, Meera V;Chen, Cheng;Douglas, Michael P;Phillips, Kathryn A

Value Health. 2023 Dec;26(12):1697-1710. doi: 10.1016/j.jval.2023.08.010. Epub 2023 Sep 22.

PubMed abstract

The costs and inequities of precision medicine for patients with prostate cancer: A call to action.

Authors: Ragavan, Meera V;Borno, Hala T

Urol Oncol. 2023 Sep;41(9):369-375. doi: 10.1016/j.urolonc.2023.04.012. Epub 2023 May 9.

PubMed abstract

Private Payer and Medicare Coverage Policies for Use of Circulating Tumor DNA Tests in Cancer Diagnostics and Treatment.

Authors: Douglas, Michael P;Ragavan, Meera V;Chen, Cheng;Kumar, Anika;Gray, Stacy W;Blakely, Collin M;Phillips, Kathryn A

J Natl Compr Canc Netw. 2023 Jun;21(6):609-616.e4. doi: 10.6004/jnccn.2023.7011..

PubMed abstract

Impact of a Comprehensive Financial Resource on Financial Toxicity in a National, Multiethnic Sample of Adult, Adolescent/Young Adult, and Pediatric Patients With Cancer.

Authors: Ragavan, Meera V;Mora, Rosa V;Winder, Kate;Incudine, Andrea;Cunningham, Rosie;Stivers, Tom;Borno, Hala T

JCO Oncol Pract. 2023 Feb;19(2):e286-e297. doi: 10.1200/OP.22.00350. Epub 2022 Nov 15.

PubMed abstract

Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic.

Authors: Ragavan, Meera V;Legaspi, Nichole;LaLanne, Alyssa;Hong, Julian C;Small, Eric J;Borno, Hala T

JAMA Oncol. 2022 Dec 01;8(12):1849-1851. doi: 10.1001/jamaoncol.2022.4919..

PubMed abstract

The evolving landscape of sex-based differences in lung cancer: a distinct disease in women.

Authors: Ragavan, Meera;Patel, Manali I

Eur Respir Rev. 2022 Mar 31;31(163):pii: 210100. doi: 10.1183/16000617.0100-2021. Epub 2022 Jan 12.

PubMed abstract

Financial Toxicity of Cancer Care: An Analysis of Financial Burden in Three Distinct Health Care Systems.

Authors: Parikh, Divya A;Ragavan, Meera;Dutta, Ritika;Garnet Edwards, Jeffrey;Dickerson, James;Maitra, Debeshi;Aggarwal, Sangeeta;Lee, Fa-Chyi;Patel, Manali I

JCO Oncol Pract. 2021 Oct;17(10):e1450-e1459. doi: 10.1200/OP.20.00890. Epub 2021 Apr 7.

PubMed abstract

Defining the clinician’s role in mitigating financial toxicity: an exploratory study.

Authors: Ragavan, Meera;Parikh, Divya;Patel, Manali

Support Care Cancer. 2021 Aug;29(8):4835-4845. doi: 10.1007/s00520-021-05984-6. Epub 2021 Feb 5.

PubMed abstract

Systemic Therapy of Extensive Stage Small Cell Lung Cancer in the Era of Immunotherapy.

Authors: Ragavan, Meera;Das, Millie

Curr Treat Options Oncol. 2020 Jun 29;21(8):64. doi: 10.1007/s11864-020-00762-8..

PubMed abstract

Understanding sex disparities in lung cancer incidence: are women more at risk?

Authors: Ragavan, Meera V;Patel, Manali I

Lung Cancer Manag. 2020 Jun 22;9(3):LMT34. doi: 10.2217/lmt-2020-0013..

PubMed abstract

Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.

Authors: Brady, Brian M;Ragavan, Meera V;Simon, Melora;Chertow, Glenn M;Milstein, Arnold

J Am Soc Nephrol. 2019 Dec;30(12):2464-2472. doi: 10.1681/ASN.2019030219. Epub 2019 Nov 14.

PubMed abstract

Back To Top